Inventory

12 Months Ended

Dec. 31, 2017

Inventory Disclosure [Abstract]

Inventory

(4)    Inventory

The Company capitalizes its purchases of saleable inventory of Vascepa from suppliers that have been qualified by the FDA. Inventories as of December 31, 2017 and 2016 consist of the following:

In thousands	December 31, 2017		December 31, 2016
Raw materials	$	7,044	$	4,430
Work in process		10,844		10,716
Finished goods		12,372		5,361
Inventory	$	30,260	$	20,507